Marker Total Assets from 2010 to 2025

MRKR Stock

USD 1.25 0.05 3.85%

Marker Therapeutics Total Assets yearly trend continues to be relatively stable with very little volatility. Total Assets are likely to drop to about 13.6 M. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

2000-03-31

Previous Quarter

11.7 M

Current Value

10.9 M

Quarterly Volatility

21.7 M

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check Marker Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Marker Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.6 M, Interest Expense of 12.9 K or Selling General Administrative of 5.6 M, as well as many indicators such as Price To Sales Ratio of 15.99, Dividend Yield of 0.0 or PTB Ratio of 3.26. Marker financial statements analysis is a perfect complement when working with Marker Therapeutics Valuation or Volatility modules.

Check out the analysis of Marker Therapeutics Correlation against competitors.

To learn how to invest in Marker Stock, please use our How to Invest in Marker Therapeutics guide.

Latest Marker Therapeutics' Total Assets Growth Pattern

Below is the plot of the Total Assets of Marker Therapeutics over the last few years. Total assets refers to the total amount of Marker Therapeutics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Marker Therapeutics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Marker Therapeutics' Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Marker Therapeutics' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 17.13 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Total Assets

Timeline

Marker Total Assets Regression Statistics

	Arithmetic Mean	20,483,327
	Geometric Mean	4,560,673
	Coefficient Of Variation	114.19
	Mean Deviation	19,282,386
	Median	13,592,229
	Standard Deviation	23,389,493
	Sample Variance	547.1T
	Range	68.1M
	R-Value	0.54
	Mean Square Error	417.5T
	R-Squared	0.29
	Significance	0.03
	Slope	2,635,517
	Total Sum of Squares	8206T

Marker Total Assets History

	2025	13.6 M
	2024	19.7 M
	2023	17.1 M
	2022	34.4 M
	2021	68.1 M
	2020	45.6 M
	2019	46.4 M

Other Fundumenentals of Marker Therapeutics

Intangibles To Total Assets

Marker Therapeutics Total Assets component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Property Plant Equipment	Current Deferred Revenue	Net Tangible Assets	Capital Surpluse	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.92	-0.81	-0.71	0.69	0.17	0.36	0.95	-0.13	0.06	0.32	0.2	0.75	0.8	-0.66	0.94	0.85	0.25
Total Stockholder Equity	0.92		-0.88	-0.69	0.49	0.16	-0.02	0.94	-0.21	-0.13	0.31	0.18	0.85	0.78	-0.73	0.95	0.92	0.11
Net Debt	-0.81	-0.88		0.52	-0.32	0.1	0.02	-0.95	0.29	0.02	-0.09	0.05	-0.7	-0.63	0.56	-0.92	-0.97	-0.15
Retained Earnings	-0.71	-0.69	0.52		-0.42	-0.68	-0.25	-0.64	0.17	0.31	-0.8	-0.64	-0.91	-0.95	0.85	-0.64	-0.54	0.39
Accounts Payable	0.69	0.49	-0.32	-0.42		-0.04	0.62	0.51	0.31	0.43	0.33	0.23	0.33	0.42	-0.32	0.53	0.4	0.54
Net Receivables	0.17	0.16	0.1	-0.68	-0.04		0.15	0.03	-0.04	-0.43	0.74	0.74	0.54	0.56	-0.48	0.08	-0.05	-0.76
Total Liab	0.36	-0.02	0.02	-0.25	0.62	0.15		0.16	0.17	0.43	0.21	0.21	-0.04	0.19	0.01	0.16	0.02	0.31
Total Current Assets	0.95	0.94	-0.95	-0.64	0.51	0.03	0.16		-0.2	0.04	0.21	0.08	0.75	0.76	-0.63	0.97	0.96	0.21
Short Term Debt	-0.13	-0.21	0.29	0.17	0.31	-0.04	0.17	-0.2		0.79	0.05	0.43	-0.18	-0.22	0.32	-0.14	-0.18	0.11
Common Stock	0.06	-0.13	0.02	0.31	0.43	-0.43	0.43	0.04	0.79		-0.32	0.03	-0.34	-0.29	0.45	0.05	0.05	0.54
Property Plant Equipment	0.32	0.31	-0.09	-0.8	0.33	0.74	0.21	0.21	0.05	-0.32		0.7	0.7	0.66	-0.57	0.24	0.14	-0.55
Current Deferred Revenue	0.2	0.18	0.05	-0.64	0.23	0.74	0.21	0.08	0.43	0.03	0.7		0.53	0.53	-0.44	0.15	0.05	-0.57
Net Tangible Assets	0.75	0.85	-0.7	-0.91	0.33	0.54	-0.04	0.75	-0.18	-0.34	0.7	0.53		0.9	-0.84	0.78	0.73	-0.37
Capital Surpluse	0.8	0.78	-0.63	-0.95	0.42	0.56	0.19	0.76	-0.22	-0.29	0.66	0.53	0.9		-0.85	0.71	0.64	-0.27
Short Long Term Debt	-0.66	-0.73	0.56	0.85	-0.32	-0.48	0.01	-0.63	0.32	0.45	-0.57	-0.44	-0.84	-0.85		-0.6	-0.54	0.26
Net Invested Capital	0.94	0.95	-0.92	-0.64	0.53	0.08	0.16	0.97	-0.14	0.05	0.24	0.15	0.78	0.71	-0.6		0.97	0.18
Net Working Capital	0.85	0.92	-0.97	-0.54	0.4	-0.05	0.02	0.96	-0.18	0.05	0.14	0.05	0.73	0.64	-0.54	0.97		0.16
Capital Stock	0.25	0.11	-0.15	0.39	0.54	-0.76	0.31	0.21	0.11	0.54	-0.55	-0.57	-0.37	-0.27	0.26	0.18	0.16

Click cells to compare fundamentals

About Marker Therapeutics Financial Statements

Marker Therapeutics shareholders use historical fundamental indicators, such as Total Assets, to determine how well the company is positioned to perform in the future. Although Marker Therapeutics investors may analyze each financial statement separately, they are all interrelated. The changes in Marker Therapeutics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Marker Therapeutics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

		Last Reported	Projected for Next Year
	Total Assets	19.7 M	13.6 M

Additional Tools for Marker Stock Analysis

When running Marker Therapeutics' price analysis, check to measure Marker Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Marker Therapeutics is operating at the current time. Most of Marker Therapeutics' value examination focuses on studying past and present price action to predict the probability of Marker Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Marker Therapeutics' price. Additionally, you may evaluate how the addition of Marker Therapeutics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC